CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Oct. 31, 2015	Oct. 31, 2014
Cash Flows From Operating Activities:
Net (loss)/income	$ (1,731,265)	$ 49,623
Adjustments to reconcile net (loss) / income to net cash used in operating activities:
Depreciation and amortization	52,661	$ 115,912
Stock compensation expense	27,344
Common stock issued for services rendered	4,500	$ 21,050
Common stock issued as make-whole payments on preferred stock	113,400	58,523
Change in fair value of derivative liabilities	315,963	(711,978)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	522,064	(601,072)
Other current assets	784	(32,294)
Net Cash Used in Operating Activities	$ (696,117)	(1,035,648)
Cash Flows From Investing Activities:
Costs incurred for patents		(13,887)
Net Cash (Used in)/Provided By Investing Activities		(13,887)
Cash Flows From Financing Activities:
Proceeds from exercise of stock options	$ 2,952	542
Net Cash Provided by Financing Activities	2,952	542
Effect of Exchange Rates on Cash	(4,372)	(5,058)
Net Decrease in Cash and Cash Equivalents	(697,537)	(1,054,051)
Cash and Cash Equivalents, Beginning of Period	749,965	3,269,489
Cash and Cash Equivalents, End of Period	$ 52,428	$ 2,215,438